Cargando…

Objective cough frequency in Idiopathic Pulmonary Fibrosis

BACKGROUND: Cough is a common presenting symptom in patients with Idiopathic Pulmonary Fibrosis (IPF). This study measured cough rates in IPF patients and investigated the association between cough and measures of health related quality of life and subjective cough assessments. In addition, IPF coug...

Descripción completa

Detalles Bibliográficos
Autores principales: Key, Angela L, Holt, Kimberley, Hamilton, Andrew, Smith, Jaclyn A, Earis, John E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902403/
https://www.ncbi.nlm.nih.gov/pubmed/20565979
http://dx.doi.org/10.1186/1745-9974-6-4
_version_ 1782183751579598848
author Key, Angela L
Holt, Kimberley
Hamilton, Andrew
Smith, Jaclyn A
Earis, John E
author_facet Key, Angela L
Holt, Kimberley
Hamilton, Andrew
Smith, Jaclyn A
Earis, John E
author_sort Key, Angela L
collection PubMed
description BACKGROUND: Cough is a common presenting symptom in patients with Idiopathic Pulmonary Fibrosis (IPF). This study measured cough rates in IPF patients and investigated the association between cough and measures of health related quality of life and subjective cough assessments. In addition, IPF cough rates were related to measures of physiological disease severity and compared to cough rates in health and other respiratory conditions. METHODS: Nineteen IPF patients, mean age 70.8 years ± 8.6, five female (26.3%) were studied. Subjects performed full pulmonary function testing, 24 hour ambulatory cough recordings, completed a cough related quality of life questionnaire (Leicester Cough Questionnaire) and subjectively scored cough severity with a visual analogue scale. Ambulatory cough recordings were manually counted and reported as number of coughs per hour. RESULTS: The 24hr cough rates were high (median 9.4, range 1.5-39.4), with day time rates much higher than night time (median 14.6, range 1.9-56.6 compared to 1.9, range 0-19.2, p = 0.003). Strong correlations were found between objective cough frequency and both the VAS (day r = 0.80, p < 0.001, night r = 0.71, p = 0.001) and LCQ (r = -0.80, p < 0.001), but not with measures of pulmonary function. Cough rates in IPF were higher than healthy subjects (p < 0.001) and asthma patients (p < 0.001) but similar to patients with chronic cough (p = 0.33). CONCLUSIONS: This study confirms objectively that cough is a major, very distressing and disabling symptom in IPF patients. The strong correlations between objective cough counts and cough related quality of life measures suggest that in IPF patient's, perception of cough frequency is very accurate.
format Text
id pubmed-2902403
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29024032010-07-13 Objective cough frequency in Idiopathic Pulmonary Fibrosis Key, Angela L Holt, Kimberley Hamilton, Andrew Smith, Jaclyn A Earis, John E Cough Research BACKGROUND: Cough is a common presenting symptom in patients with Idiopathic Pulmonary Fibrosis (IPF). This study measured cough rates in IPF patients and investigated the association between cough and measures of health related quality of life and subjective cough assessments. In addition, IPF cough rates were related to measures of physiological disease severity and compared to cough rates in health and other respiratory conditions. METHODS: Nineteen IPF patients, mean age 70.8 years ± 8.6, five female (26.3%) were studied. Subjects performed full pulmonary function testing, 24 hour ambulatory cough recordings, completed a cough related quality of life questionnaire (Leicester Cough Questionnaire) and subjectively scored cough severity with a visual analogue scale. Ambulatory cough recordings were manually counted and reported as number of coughs per hour. RESULTS: The 24hr cough rates were high (median 9.4, range 1.5-39.4), with day time rates much higher than night time (median 14.6, range 1.9-56.6 compared to 1.9, range 0-19.2, p = 0.003). Strong correlations were found between objective cough frequency and both the VAS (day r = 0.80, p < 0.001, night r = 0.71, p = 0.001) and LCQ (r = -0.80, p < 0.001), but not with measures of pulmonary function. Cough rates in IPF were higher than healthy subjects (p < 0.001) and asthma patients (p < 0.001) but similar to patients with chronic cough (p = 0.33). CONCLUSIONS: This study confirms objectively that cough is a major, very distressing and disabling symptom in IPF patients. The strong correlations between objective cough counts and cough related quality of life measures suggest that in IPF patient's, perception of cough frequency is very accurate. BioMed Central 2010-06-21 /pmc/articles/PMC2902403/ /pubmed/20565979 http://dx.doi.org/10.1186/1745-9974-6-4 Text en Copyright ©2010 Key et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Key, Angela L
Holt, Kimberley
Hamilton, Andrew
Smith, Jaclyn A
Earis, John E
Objective cough frequency in Idiopathic Pulmonary Fibrosis
title Objective cough frequency in Idiopathic Pulmonary Fibrosis
title_full Objective cough frequency in Idiopathic Pulmonary Fibrosis
title_fullStr Objective cough frequency in Idiopathic Pulmonary Fibrosis
title_full_unstemmed Objective cough frequency in Idiopathic Pulmonary Fibrosis
title_short Objective cough frequency in Idiopathic Pulmonary Fibrosis
title_sort objective cough frequency in idiopathic pulmonary fibrosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902403/
https://www.ncbi.nlm.nih.gov/pubmed/20565979
http://dx.doi.org/10.1186/1745-9974-6-4
work_keys_str_mv AT keyangelal objectivecoughfrequencyinidiopathicpulmonaryfibrosis
AT holtkimberley objectivecoughfrequencyinidiopathicpulmonaryfibrosis
AT hamiltonandrew objectivecoughfrequencyinidiopathicpulmonaryfibrosis
AT smithjaclyna objectivecoughfrequencyinidiopathicpulmonaryfibrosis
AT earisjohne objectivecoughfrequencyinidiopathicpulmonaryfibrosis